Response to Comment on: Jones et al. Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study). Diabetes Care 2011;34:828–837

Yazar: Jones, T. Hugh, Howell, Julian D., Channer, Kevin S.
Baskı/Yayın Bilgisi 2011

Use of transdermal and intravenous granisetron and the ability of the Hesketh score to assess nausea and vomiting induced by multiday chemotherapy

Yazar: Boccia, Ralph V, Clark, Gemma, Howell, Julian D
Baskı/Yayın Bilgisi 2012

Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly emetogenic multi-day chemothe...

Yazar: Boccia, Ralph V., Gordan, Lucio N., Clark, Gemma, Howell, Julian D., Grunberg, Steven M.
Baskı/Yayın Bilgisi 2010

Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)

Yazar: Jones, T. Hugh, Arver, Stefan, Behre, Hermann M., Buvat, Jacques, Meuleman, Eric, Moncada, Ignacio, Morales, Antonio Martin, Volterrani, Maurizio, Yellowlees, Ann, Howell, Julian D., Channer, Kevin S.
Baskı/Yayın Bilgisi 2011